Condition
Intestinal Helminthiasis
Total Trials
6
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
17%
1 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 1 (1)
P 4 (1)
Trial Status
Completed4
Withdrawn1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT03079700Completed
Immune Modulation From Trichuris Suis
NCT02597556Phase 4WithdrawnPrimary
The Impact of Anthelmintic Treatment on the Incidence of Diarrheal Disease in Vietnamese School Children
NCT02399683Completed
Immune Modulation From Trichuris Trichiura
NCT01658774Not ApplicableCompletedPrimary
Impact of Repeated Anthelmintic Treatment on the Risk of Malaria in Kenyan School Children
NCT01640626Phase 1CompletedPrimary
Impact of Health Education on School Children
NCT01541631Not ApplicableUnknown
A Study of Co-infections of HIV-1 and Schistosoma Mansoni and Its Impact on Praziquantel Treatment Outcomes
Showing all 6 trials